Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder.
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995 Apr 01; 37(7):462-6.
View in:
PubMed
subject areas
Adult
Agoraphobia
Arousal
Benzodiazepinones
Double-Blind Method
Female
Humans
Male
Middle Aged
Panic Disorder
Personality Inventory
Phenylurea Compounds
Receptor, Cholecystokinin B
Receptors, Cholecystokinin
Tetragastrin
Treatment Outcome
authors with profiles
James C. Ballenger